| Serial Number | 79350973 |
| Word Mark | ARICEUM |
| Filing Date | Monday, August 22, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 5, 2024 |
| Registration Number | 7318209 |
| Registration Date | Tuesday, March 5, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 19, 2023 |
| Goods and Services | Pharmaceuticals for use in the treatment of cancer; pharmaceutical drugs for use in the treatment of cancer; pharmaceutical preparations for use in the treatment of cancer; injectable pharmaceuticals for use in the treatment of cancer; chemico-pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations and substances for use in the treatment of cancer; pharmaceutical preparations for human use for use in the treatment of cancer; synthetic peptides for pharmaceutical purposes for use in the diagnosis and treatment of cancer; pharmaceutical preparations for medical purposes for use in the treatment of cancer; pharmaceutical preparations for the prevention of tumours; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; radioactive substances for medical purposes; radioactive materials for medical purposes; radioactive elements for medical use |
| Goods and Services | Pharmaceutical products development; pharmaceutical product evaluation; testing of pharmaceuticals; research of pharmaceuticals; pharmaceutical research and development; research relating to pharmaceuticals; conducting clinical trials for pharmaceutical products of others; development of pharmaceutical preparations and medicines; research on the subject of pharmaceuticals; research and development for the pharmaceutical industry; research and development in the pharmaceutical and biotechnology fields; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceutical preparations for treating malignant tumours |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 30, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 30, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Ariceum Therapeutics GmbH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | DE |
| Party Name | Ariceum Therapeutics GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | DE |
| Party Name | Ariceum Therapeutics GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | DE |
| Event Date | Event Description |
| Thursday, June 15, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, September 29, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, September 30, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 4, 2022 | APPLICATION FILING RECEIPT MAILED |
| Thursday, June 8, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, June 14, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, July 20, 2023 | REFUSAL PROCESSED BY MPU |
| Thursday, July 20, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, August 7, 2023 | REFUSAL PROCESSED BY IB |
| Thursday, November 9, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, November 9, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, November 10, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, November 13, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 29, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, December 19, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, November 29, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, November 29, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Tuesday, December 19, 2023 | NOTIFICATION PROCESSED BY IB |
| Tuesday, December 19, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 5, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Friday, August 16, 2024 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, June 6, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, March 5, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Thursday, June 6, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Thursday, June 6, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |